Press Releases

Roswell Park Deputy Director Kunle Odunsi, MD, PhD, right, with Professor Stanisław Kistryn of Jagiellonian University in Poland. The two centers will partner on educational and research initiatives.

Roswell Park Establishes Partnership with Jagiellonian University in Krakow, Poland

Thursday, November 15, 2018
Roswell Park has formed an academic cooperation agreement with the Jagiellonian University (JU) in Kraków, Poland. The collaboration will see the two centers exchanging staff, students and scientific resources to jointly undertake basic, translational and clinical research in order to advance the development of cancer therapies to benefit patients worldwide.

Dr. Candace Johnson, Leecia Eve Honored Among Women’s Power 100

Roswell Park’s CEO and cancer center’s newest board member named to inaugural list from City & State
Tuesday, November 13, 2018
Roswell Park Comprehensive Cancer Center’s President and CEO, Candace S. Johnson, PhD, has been named to a new list of the most powerful female leaders in New York. City & State, a media company covering government and politics in New York, included Dr. Johnson on its New York Women’s Power 100 list, which honors the 100 most influential women in government, public affairs, business, culture and social services. Also named to this new list of distinguished New Yorkers is Leecia Eve, JD, who was recently appointed to the Roswell Park Board of Directors by Gov. Andrew Cuomo.

Roswell Park Recognized as Center with ‘Great Oncology Program’

Becker’s Hospital Review has included Roswell Park on national list since feature debuted in 2010
Monday, November 5, 2018
Roswell Park has again been named to Becker’s Hospital Review’s 100 Hospitals and Health Systems with Great Oncology Programs, an annual list of centers that are national leaders in patient care, cancer outcomes and research. Roswell Park is one of only six New York State centers to be included, and the only one in Western and Upstate New York.

Roswell Park Alliance Foundation Earns Highest Possible Rating of Four Stars From Charity Navigator

Tuesday, October 23, 2018
The Roswell Park Alliance Foundation has received the coveted ranking of 4 out of 4 stars from Charity Navigator, America’s largest independent charity evaluator, for its fourth consecutive year.

Expert in Gastrointestinal Cancers Joins Roswell Park as Co-Director of Liver and Pancreas Tumor Center

Wednesday, October 17, 2018
Roderich Schwarz, MD, PhD, has been appointed as the new Co-Director of the Liver and Pancreas Tumor Center at Roswell Park Comprehensive Cancer Center. He will also serve as a Professor of Oncology in the Department of Surgical Oncology.

Roswell Park’s Dr. Kunle Odunsi Elected to the National Academy of Medicine

Monday, October 15, 2018
Kunle Odunsi, MD, PhD, Deputy Director of Roswell Park Comprehensive Cancer Center, has been elected to the National Academy of Medicine — a distinguished lifetime designation that is considered one of the highest honors in health and medicine. The election of new members recognized for their outstanding professional achievements and commitment to service was announced today at the Academy’s annual meeting in Washington, D.C.

Roswell Park’s Chief of Breast Medicine Honored by Susan G. Komen® Upstate New York

Tuesday, October 9, 2018

BUFFALO, N.Y. — Ellis Levine, MD, the Chief of Breast Medicine at Roswell Park Comprehensive Cancer Center, received the Susan G. Komen® Upstate New York Hope Award on Saturday, October 6.

Compound Derived From Chinese Tree Bark Shows Promise as Treatment for Pancreatic Cancer

Wednesday, October 3, 2018
A new derivative of a compound found in the bark of a rare Chinese tree has powerful anticancer properties and a low toxicity profile, according to researchers at Roswell Park Comprehensive Cancer Center. Results of their study of the effects of the compound F118 in pancreatic cancer were published today in the Journal of Experimental & Clinical Cancer Research.

Roswell Park Lung Cancer Expert Shares Initial Findings From First North American Study of CIMAvax

Wednesday, September 26, 2018
Initial results from the first North American clinical trial of CIMAvax-EGF show that this Cuban-developed immunotherapy is safe, well tolerated and worthy of further study. Principal Investigator Grace Dy, MD, of Roswell Park Comprehensive Cancer Center shared the findings yesterday at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada.

Governor Cuomo Announces First-Ever Biotech Venture Between U.S. and Cuba to Research and Develop New Cancer Treatments

Wednesday, September 26, 2018
Governor Andrew M. Cuomo today announced Buffalo-based Roswell Park Comprehensive Cancer Center has formed Innovative Immunotherapy Alliance S.A., the first-ever biotech venture between the U.S. and Cuba. The announcement marks a significant milestone of progress following Governor Cuomo’s landmark trade mission to Cuba in April 2015, where he facilitated this historic partnership between Roswell Park and the Center for Molecular Immunology. This historic step will advance the research and development of new cancer medicines that may prolong and enhance survival for thousands of U.S. patients.

Roswell Park Awarded More Than $6 Million in Moonshot Funds to Lead New Data Management Resource

Tuesday, September 25, 2018
Through a grant award provided by the Cancer MoonshotSM, Roswell Park Comprehensive Cancer Center will support and advance some of the nation’s most ambitious cancer research projects.

Roswell Park and URMC To Create $19 Million Research Program Focused on Flavored Tobacco

Thursday, September 20, 2018
The expertise of two regional research teams has earned a federal grant of nearly $20 million to create the nation’s first program dedicated to the study of flavored tobacco.